Base
Notice2025-009772025-01-16

National Cancer Institute; Notice of Closed Meetings

Health and Human Services Department, National Institutes of Health

Action & Dates

Dates
February 12, 2025.

Document Excerpt

Document Headings Document headings vary by document type but may contain the following: the agency or agencies that issued and signed a document the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to the agency docket number / agency internal file number the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions See the Document Drafting Handbook for more details. Department of Health and Human Services National Institutes of Health Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel; PLCO U01 SEP Review Meeting. Date: February 12, 2025. Time: 10:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Address: National Cancer Institute at Shady Grove, 9609 Medical Center Drive, Room 7W102, Rockville, Maryland 20850. Meeting Format: Virtual Meeting. Contact Person: Shakeel Ahmad, Ph.D., Branch Chief, Research Technology and Contract Review, Branch Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W102, Rockville, Maryland 20850, 240-276-6442, ahmads@mail.nih.gov . Name of Committee: National Cancer Institute Special Emphasis Panel; TEP-7: SBIR Contract Review Meeting (Review of SBIR Topics 431 and 439). Date: February 20, 202

Read full document on FederalRegister.gov →

Full Document

Citation: 90 FR 4752